Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Leveraging genomic, metabolomic, and proteomic data to identify clinically-relevant subtypes and new pathways driving risk of coronary artery disease
FY 2020-21
Summary
Heart disease is the second leading cause of death in Canada and affects millions of individuals each year. Despite efforts to reduce disease risk with healthy lifestyles and medications, these strategies are not always successful. The variation in effectiveness may be linked to differences in an individual's genetic make-up (i.e. DNA), resulting in different biological mechanisms that drive heart disease. Here, I propose to uncover new disease-driving mechanisms and develop methods to stratify individuals by their main biological driver for heart disease. To do so, we can leverage 'genetic risk scores'-a method to aggregate information from many sites of DNA variation into a single measure of disease risk-along with information obtained by studying circulating blood molecules or 'biomarkers' (ex. fats and proteins) to reveal new insights. For example, abnormal biomarker measurements in individuals with a high genetic risk score, indicating a high inherited risk for heart disease, can highlight dysfunctional biological pathways. Therefore, by aggregating genetic and biomarker information, we can develop new genetic risk scores specific to these pathways, and use them to identify individuals likely to have heart disease because of a particular biological mechanism. Canadians will greatly benefit from this work because: 1) the new genetic risk scores to stratify individuals by biological driver for heart disease will empower clinicians to prescribe personalized risk-reduction strategies; and 2) the discovery of new dysfunctional disease-causing mechanisms provide researchers an opportunity to develop new drugs to target those pathways and continue to reduce risk of heart disease.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
436260
Name
Dron Jacqueline S
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Leveraging genomic, metabolomic, and proteomic data to identify clinically-relevant subtypes and new pathways driving risk of coronary artery disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Association Study; Biomarkers; Clinical Risk Prediction; Cluster Analysis; Common Disease; Coronary Artery Disease; Genomic; Metabolomics; Polygenic Risk Score; Proteomics
Abstract
Heart disease is the second leading cause of death in Canada and affects millions of individuals each year. Despite efforts to reduce disease risk with healthy lifestyles and medications, these strategies are not always successful. The variation in effectiveness may be linked to differences in an individual's genetic make-up (i.e. DNA), resulting in different biological mechanisms that drive heart disease. Here, I propose to uncover new disease-driving mechanisms and develop methods to stratify individuals by their main biological driver for heart disease. To do so, we can leverage 'genetic risk scores'-a method to aggregate information from many sites of DNA variation into a single measure of disease risk-along with information obtained by studying circulating blood molecules or 'biomarkers' (ex. fats and proteins) to reveal new insights. For example, abnormal biomarker measurements in individuals with a high genetic risk score, indicating a high inherited risk for heart disease, can highlight dysfunctional biological pathways. Therefore, by aggregating genetic and biomarker information, we can develop new genetic risk scores specific to these pathways, and use them to identify individuals likely to have heart disease because of a particular biological mechanism. Canadians will greatly benefit from this work because: 1) the new genetic risk scores to stratify individuals by biological driver for heart disease will empower clinicians to prescribe personalized risk-reduction strategies; and 2) the discovery of new dysfunctional disease-causing mechanisms provide researchers an opportunity to develop new drugs to target those pathways and continue to reduce risk of heart disease.
Competitiondate
202010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Dron, Jacqueline S
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~